Dietary supplement

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog® as Groundbreaking Dietary Supplement for Cognitive Support

Retrieved on: 
Tuesday, March 26, 2024

MORRISTOWN, N.J., March 26, 2024 /PRNewswire/ -- PLT Health Solutions, Inc. announced BioTRUST Nutrition® LLC, a leading eCommerce-based nutrition brand with a portfolio of high-quality, science-backed products focused on healthy aging and improving healthspan, has introduced a new product targeted at providing brain longevity and cognitive support called Eternal Mind®. The new product features PLT's Nutricog® Cognitive Performance Complex, an ingredient that has been clinically demonstrated to provide significant improvements across multiple cognitive domains, including learning, memory, attention, focus, and executive function, where increases in cognitive speed were seen concurrently with improvements in accuracy while multitasking. In addition, clinical science showed that Nutricog doubled levels brain-derived neurotrophic factor (BDNF), a neuroprotein involved in the brain's ability to adapt to new information.

Key Points: 
  • Eternal Mind is available direct-to-consumer from the BioTRUST Nutrition website ( www.biotrust.com ) and via Amazon.
  • "Brain and cognitive health are a significant concern for many Americans, especially as we age.
  • However, navigating the cognitive supplement market can be challenging due to the prevalence of expensive products with ambiguous 'proprietary blends' and vague claims," Chris Marschall said.
  • According to BioTRUST®, Eternal Mind is backed by the latest science in brain health.

Fighting back; the battle between Meta (Facebook) and Curios over "Open Meta" trademark

Retrieved on: 
Tuesday, March 26, 2024

AUSTIN, Texas, March 26, 2024 /PRNewswire-PRWeb/ -- In a strange turn of events, Facebook changed its name to Meta Platforms, Inc. ("MPI") as it tries to commandeer the common term "META", which is widely used throughout the digital world.  MPI's behavior is a clear tactic being used to bully other companies where there is a significant difference in power and resources.

Key Points: 
  • Curios, Inc. ("Curios") and a handful of others, are fighting back against MPI's bullying.
  • Trademark Office had approved Curios' trademark application (Serial No.
  • Thus, no one company should have exclusive rights to such a widely used and common term such as "META".
  • While the odds may be stacked against Curios and others fighting a Goliath, Curios remains resolute in its commitment to defending its OPEN META trademark and to not let MPI steal the word "META" out of the mouths of all who use this term.

Access to Nutrition Initiative study reveals that Food for infants and toddlers from leading brands fails to meet marketing and nutritional standards

Retrieved on: 
Tuesday, March 26, 2024

UTRECHT, The Netherlands, March 26, 2024 /PRNewswire/ -- The Access to Nutrition Initiative (ATNI) unveils three assessments showing inappropriate marketing and nutritional inadequacies of foods intended for infants and young children.

Key Points: 
  • UTRECHT, The Netherlands, March 26, 2024 /PRNewswire/ -- The Access to Nutrition Initiative (ATNI) unveils three assessments showing inappropriate marketing and nutritional inadequacies of foods intended for infants and young children.
  • None of the commercial complementary food products for infants and young children were found suitable for promotion for consumption by children aged 6 months to three years.
  • The first study shows only 35% meet all nutritional requirements, with 25-33% of products assessed containing excessive levels of sugar or inappropriate energy levels.
  • said Kathy Spahn, Board Member of the Access to Nutrition Initiative (ATNI) and former President and CEO, Helen Keller International.

RWJBarnabas Health and Rutgers Health to Showcase Breakthrough Cardiology Data at the American College of Cardiology Scientific Session & Expo

Retrieved on: 
Monday, March 25, 2024

WEST ORANGE, N.J., March 25, 2024 /PRNewswire/ -- Physician-scientists from RWJBarnabas Health and Rutgers Health will present an extensive portfolio of innovative cardiovascular data from their clinical research program at the American College of Cardiology's (ACC) Annual Scientific Session & Expo in Atlanta, Georgia on April 6 to 8, 2024. A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.

Key Points: 
  • A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.
  • RWJBarnabas Health cardiac centers of excellence are nationally recognized for patient care and superior outcomes, including being named as one of Becker's top 100 Great Heart Programs in the country and recognized by American College of Cardiology as a Proven Quality Program.
  • Prior studies suggest that distinct patient subgroups with aortic stenosis may experience left ventricular systolic and diastolic dysfunction before the development of severe AS.
  • The study included patients who had received an angiogram done within 14 days of the CMR.

Revolutionary Alcohol Recovery Supplement Launches: Introducing the Drinkers Vitamin

Retrieved on: 
Monday, March 25, 2024

FORT COLLINS, Colo., March 25, 2024 /PRNewswire/ -- The Drinkers Vitamin is delighted to unveil its groundbreaking alcohol recovery supplement, poised to revolutionize the way individuals approach post-drinking recovery.

Key Points: 
  • FORT COLLINS, Colo., March 25, 2024 /PRNewswire/ -- The Drinkers Vitamin is delighted to unveil its groundbreaking alcohol recovery supplement, poised to revolutionize the way individuals approach post-drinking recovery.
  • Developed with a unique blend of vitamins, antioxidants, and electrolytes, The Drinkers Vitamin is set to redefine the morning after drinking experience.
  • The Drinkers Vitamin sets itself apart by offering a comprehensive solution that supports the body's ability to metabolize alcohol efficiently resulting in quicker recovery and mental clarity after a night out.
  • Key Benefits of The Drinkers Vitamin Include:
    Scheduled for an exclusive launch on the official website https://thedrinkersvitamin.com/ , The Drinkers Vitamin invites individuals to embrace a healthier approach to alcohol consumption and recovery.

Fuel Your Inner Athlete: Garden of Life® Introduces Sport Line Extension

Retrieved on: 
Monday, March 25, 2024

PALM BEACH GARDENS, Fla., March 25, 2024 /PRNewswire/ -- Garden of Life®, a Nestlé Health Science brand and leader in supplements made from clean, traceable, non-GMO ingredients, is introducing exciting new products within the beloved Sport collection. The latest launch is made to deliver clean, clinically studied performance support that's easy to fit into any daily routine.

Key Points: 
  • The latest launch is made to deliver clean, clinically studied performance support that's easy to fit into any daily routine.
  • Garden of Life's new Sport products combine certified Non-GMO Project Verified and Certified USDA Organic ingredients into multi-tasking formulas that support everything from a daily nature walk to the quest for a gold medal.
  • "We are proud to launch the next generation of Garden of Life Sport products based on consumer demands, formulated with new innovative ingredients and third-party certifications to maintain the highest standards."
  • This product is not intended to diagnose, treat, cure or prevent any disease.

Bionique Launches Even & Renew, the Latest Addition to the Wellbeing Pro Series, Offering Hope for Those Battling Skin Dark Spots and Hyperpigmentation

Retrieved on: 
Sunday, March 24, 2024

SYDNEY, March 24, 2024 /PRNewswire-PRWeb/ -- The pursuit of a flawless and even skin tone is a universal desire, with individuals across the globe seeking effective solutions to combat pigmentation issues. Research conducted by ENSOUL Medical Clinic in 2023 has shed light on the prevalence of skin problems related to pigmentation among Asians, stemming from their increased melanin production.

Key Points: 
  • Skin discoloration, often caused by excessive melanin secretion or irregular distribution within the skin, can be influenced by various factors including hormonal imbalances, genetic predisposition, sun exposure, and lifestyle habits.
  • In response to this widespread concern, people continuously explore a myriad of methods to address these issues and achieve their desired complexion.
  • Even & Renew has successfully passed its rigorous review to become an AUST listed product, demonstrating its exceptional quality and significant efficacies.
  • Bionique is dedicated to fulfilling consumers' beauty aspirations by continuing to introduce efficacy-focused oral supplements in the future.

FDA Roundup: March 22, 2024

Retrieved on: 
Friday, March 22, 2024

On Thursday, the FDA updated the Breakthrough Devices Program webpage to update the device designations data and the marketing authorizations list.

Key Points: 
  • On Thursday, the FDA updated the Breakthrough Devices Program webpage to update the device designations data and the marketing authorizations list.
  • From launch of the Breakthrough Devices Program through December 31, 2023, in total, the FDA granted 933 Breakthrough Devices designations and authorized 95 Breakthrough Devices for marketing.
  • On Thursday, the FDA approved safety labeling changes for fluorouracil injection products.
  • These changes also enable the FDA to more effectively respond to new information on the safety and use of food contact substances.

FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy

Retrieved on: 
Thursday, March 21, 2024

SILVER SPRING, Md., March 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.

Key Points: 
  • SILVER SPRING, Md., March 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.
  • Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.
  • "This approval provides another treatment option to help reduce the burden of this progressive, devastating disease for individuals impacted by DMD regardless of genetic mutation."
  • DMD is the most common childhood form of muscular dystrophy and typically affects males.

Global Fitness CEO Calls Out New 'Study' on Intermittent Fasting

Retrieved on: 
Thursday, March 21, 2024

CLEARWATER, Fla., March 21, 2024 /PRNewswire-PRWeb/ -- The FASTer Way to Fat Loss, a global digital fitness and nutrition franchise, today reaffirmed its commitment to the practice of intermittent fasting as a safe and effective strategy for its clients. This comes in response to a recent study conducted by a Chinese university and shared by the American Heart Association (AHA) that raised concerns about the potential health risks associated with intermittent fasting.

Key Points: 
  • Fitness industry expert and CEO of global fitness company, FASTer Way to Fat Loss, stands firm in its commitment to continue intermittent fasting for clients despite new 'study.'
  • CLEARWATER, Fla., March 21, 2024 /PRNewswire-PRWeb/ -- The FASTer Way to Fat Loss, a global digital fitness and nutrition franchise, today reaffirmed its commitment to the practice of intermittent fasting as a safe and effective strategy for its clients.
  • This comes in response to a recent study conducted by a Chinese university and shared by the American Heart Association (AHA) that raised concerns about the potential health risks associated with intermittent fasting.
  • Since 2016, The FASTer Way to Fat Loss has successfully implemented intermittent fasting as part of its comprehensive approach to health and wellness.